Argent Biopharma Ltd (RGT) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.379x

Based on the latest financial reports, Argent Biopharma Ltd (RGT) has a cash flow conversion efficiency ratio of 0.379x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.27 Million ≈ $-2.31 Million USD) by net assets (AU$-8.63 Million ≈ $-6.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Argent Biopharma Ltd - Cash Flow Conversion Efficiency Trend (2006–2023)

This chart illustrates how Argent Biopharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Argent Biopharma Ltd carry for a breakdown of total debt and financial obligations.

Argent Biopharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Argent Biopharma Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Prima Cakrawala Abadi PT JK:PCAR	0.183x
Lanesborough Real Estate Investment Trust V:LRT-UN	0.011x
Biosergen AS ST:BIOSGN	-0.954x
Klarsen SA PA:ALKLA	0.061x
CDN Maverick Capital Corp. F:338B	-0.034x
Fluicell AB ST:FLUI	-0.114x
MOBILUM TECHNOLOGIES INC. F:C0B	N/A
Infinitum Copper Corp V:INFI	-7.611x

Annual Cash Flow Conversion Efficiency for Argent Biopharma Ltd (2006–2023)

The table below shows the annual cash flow conversion efficiency of Argent Biopharma Ltd from 2006 to 2023. For the full company profile with market capitalisation and key ratios, see Argent Biopharma Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-06-30	AU$-8.03 Million ≈ $-5.68 Million	AU$-11.99 Million ≈ $-8.48 Million	1.492x	+163.57%
2022-06-30	AU$5.18 Million ≈ $3.67 Million	AU$-12.16 Million ≈ $-8.60 Million	-2.347x	-170.67%
2021-06-30	AU$13.83 Million ≈ $9.78 Million	AU$-11.99 Million ≈ $-8.48 Million	-0.867x	+73.05%
2020-06-30	AU$3.09 Million ≈ $2.19 Million	AU$-9.96 Million ≈ $-7.05 Million	-3.218x	-446.82%
2019-06-30	AU$10.80 Million ≈ $7.64 Million	AU$-6.35 Million ≈ $-4.50 Million	-0.588x	-26.86%
2018-06-30	AU$12.69 Million ≈ $8.98 Million	AU$-5.89 Million ≈ $-4.17 Million	-0.464x	-57.30%
2017-06-30	AU$15.79 Million ≈ $11.17 Million	AU$-4.66 Million ≈ $-3.29 Million	-0.295x	-7.40%
2016-06-30	AU$11.73 Million ≈ $8.30 Million	AU$-3.22 Million ≈ $-2.28 Million	-0.275x	+14.35%
2015-06-30	AU$1.93 Million ≈ $1.36 Million	AU$-617.71K ≈ $-437.07K	-0.321x	-208.50%
2014-06-30	AU$4.55 Million ≈ $3.22 Million	AU$-472.74K ≈ $-334.49K	-0.104x	-54.01%
2013-06-30	AU$7.94 Million ≈ $5.62 Million	AU$-536.08K ≈ $-379.31K	-0.067x	+86.00%
2012-06-30	AU$787.42K ≈ $557.15K	AU$-379.45K ≈ $-268.48K	-0.482x	-17.80%
2011-06-30	AU$828.30K ≈ $586.08K	AU$-338.82K ≈ $-239.74K	-0.409x	-223.14%
2010-06-30	AU$-3.14 Million ≈ $-2.22 Million	AU$-1.04 Million ≈ $-737.66K	0.332x	-99.30%
2009-06-30	AU$-8.79K ≈ $-6.22K	AU$-416.04K ≈ $-294.38K	47.331x	+20017.04%
2008-06-30	AU$1.94 Million ≈ $1.37 Million	AU$-460.26K ≈ $-325.67K	-0.238x	+44.28%
2007-06-30	AU$3.81 Million ≈ $2.70 Million	AU$-1.63 Million ≈ $-1.15 Million	-0.426x	-2973.25%
2006-06-30	AU$2.76 Million ≈ $1.95 Million	AU$41.00K ≈ $29.01K	0.015x	--

About Argent Biopharma Ltd

AU:RGT Australia Drug Manufacturers - Specialty & Generic

Market Cap

$2.46 Million

AU$3.48 Million AUD

Market Cap Rank

#29467 Global

#1735 in Australia

Share Price

AU$0.04

Change (1 day)

+5.26%

52-Week Range

AU$0.03 - AU$0.15

All Time High

AU$125.00